News Cancer drug could cost NHS £4.7m per year of patient life, s... Roche's Erivedge is latest cancer drug to fall foul of NICE number-crunching.
News Myeloma UK launches stratified medicine trial of Darzalex co... Research-based charities are taking on an ever-growing role in frontline clinical research, and Myeloma UK has just launched a ‘stratified medicine’ trial aimed at helping high risk patient
News FDA rejects Mylan and Biocon biosimilar, citing manufacturin... Neulasta biosimilar hits trouble with regulators because of manufacturing issues
News Lilly's Verzenio fails in KRAS-mutated lung cancer Lilly's Verzenio has failed to show benefits in lung cancer patients with a KRAS mutation, denting the company's hopes of millions in extra revenues.
News Leukaemia patients to get access to AbbVie's Venclyxto via C... Cancer Drugs Fund will reimburse medicine on interim basis
Patients Patients not just at the table, but creating their own: In c... Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
